In this blog post, we'll delve into the relationship between GLP-1 and constipation, offering insights, tips, and friendly advice for those on their path to a healthier lifestyle
Comparison of gut microbiota in exclusively breast-fed and formula-fed babies: a study of 91 term infants
SGLT2, sodiumglucose transporter 2
Weight regain risk during the transition Research consistently shows that approximately two-thirds of patients regain weight when they stop GLP-1 receptor agonist therapy
This means that individuals who use these treatments as part of a comprehensive weight loss plan, including diet and exercise, are more likely to keep the weight off in the long run
Live birth rates were significantly lower in women with class I and class IIIII obesity